Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

02.05.2019 | obituary

Obituary for Professor Michael Steurer

verfasst von: PD Dr. Alexander Egle

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Auszug

Michael Steurer was my big, strong, great friend. He left us on March 11, 2019 after fighting his bravest battle against a disease he knew so well from years of treating his patients. He left a mourning wife and two fantastic daughters at age of three and six. He was a wonderful father and devoted husband and was enormously proud and happy to have his family. The catastrophic disease, with its final result—his much too early departure—leaves us all speechless and stunned. He was a very special person to have known. …
Nächster Artikel Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology
Metadaten
Titel
Obituary for Professor Michael Steurer
verfasst von
PD Dr. Alexander Egle
Publikationsdatum
02.05.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0489-2

Weitere Artikel der Ausgabe 2/2019

Whom to screen? A view on lung cancer screening from the pneumologist’s perspective

  • Open Access
  • short review

Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab

  • original report

Direct oral anticoagulants: a treatment option in oncological patients

  • Open Access
  • special report

Tobacco control: prevention and cessation in Europe

  • Open Access
  • short review

Lung cancer screening—the surgeon’s perspective

  • Open Access
  • short review

Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

  • editorial